Natera Validates Signatera for Lymphoma MRD Assessment
AUSTIN, Texas, September 1, 2026 Natera announced publication of new clinical data in Blood Neoplasia supporting the prognostic and...
hematologic malignancies
Advertisement
LEO Pharma Acquires Dersimelagon for Rare Skin Diseases
BALLERUP, DENMARK, August 18, 2026 LEO Pharma has entered into an agreement to acquire worldwide rights to dersimelagon from...
Smith+Nephew and Imperial Advance Surgical Robotics
LONDON, August 18, 2026 Smith+Nephew and Imperial College London have launched a new five-year partnership to accelerate innovation in...
InnoCare Advances Phase III AML Trial of Mesutoclax
BEIJING, August 18, 2026 InnoCare Pharma announced that China’s Center for Drug Evaluation (CDE) of the National Medical Products...
Sanofi’s MenQuadfi Receives EU Approval for Infants From Six Weeks of Age
PARIS, Aug. 4, 2026 Sanofi announced that the European Commission (EC) has approved an expanded indication for MenQuadfi® (Meningococcal...
Advertisements
Nurix Therapeutics Enrolls First Patient in Phase 3 DAYBreak CLL-306 Trial of Bexobrutideg
BRISBANE, Calif., Aug. 4, 2026 Nurix Therapeutics, Inc. announced the enrollment of the first patient in the registrational Phase...
Nabsys Partners With Indiana University on Cancer Genomics
PROVIDENCE, R.I., July 31, 2026 Nabsys 2.0, LLC has entered into a multi-year research collaboration with Indiana University School...
TScan Therapeutics Doses First Patient in Phase 3 ALLOHA-2 Trial
WALTHAM, Mass., July 29, 2026 TScan Therapeutics announced that the first patient has been dosed with TSC-101 in the...
Zepto Life Launches FungiFlex Tests for Rapid Fungal Diagnosis
IRVINE, Calif., July 15, 2026 Zepto Life Technology has expanded its FungiFlex® molecular diagnostics portfolio with the launch of...
Montefiore Einstein Expands CGM Use to Improve Diabetes Care
BRONX, New York, July 6, 2026 Montefiore Einstein investigators have published new research demonstrating that expanding the use of...
Advertisement
